Evidence map›Paper›PMID 30089832›Full record

ArticleTranslational psychiatry2018

Serotonin transporter promoter methylation in peripheral cells and neural responses to negative stimuli: A study of adolescent monozygotic twins.

Elmira Ismaylova, Melissa L Lévesque, Florence B Pomares, Moshe Szyf, Zsofia Nemoda, Cherine Fahim, Frank Vitaro, Mara Brendgen, Ginette Dionne, Michel Boivin and 2 more

Open access · goldAbstract readTwin Study
In one paragraph

Article in Translational psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Frontoinsular Network Markers of Current and Future Adolescent Mood Health.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Elmira IsmaylovaCHU Sainte-Justine Research Centre, Montreal, Canada.
Melissa L LévesqueCHU Sainte-Justine Research Centre, Montreal, Canada.
Florence B PomaresCHU Sainte-Justine Research Centre, Montreal, Canada.ORCID http://orcid.org/0000-0002-1139-9825
Moshe SzyfDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Zsofia NemodaDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Cherine FahimCHU Sainte-Justine Research Centre, Montreal, Canada.
Frank VitaroCHU Sainte-Justine Research Centre, Montreal, Canada.
Mara BrendgenCHU Sainte-Justine Research Centre, Montreal, Canada.
Ginette DionneSchool of Psychology, University of Laval, Quebec, Canada.
Michel BoivinSchool of Psychology, University of Laval, Quebec, Canada.
Richard E TremblayCHU Sainte-Justine Research Centre, Montreal, Canada.
Linda BooijCHU Sainte-Justine Research Centre, Montreal, Canada. linda.booij@concordia.ca.
Centre Hospitalier Universitaire Sainte-Justine · CAMcGill University · CANational Research Tomsk State University · RUUniversité du Québec à Montréal · CAUniversité Laval · CAUniversity College Dublin · IE

Funding

CIHR
6 · The paper itself

Abstract

Several studies have examined associations between peripheral DNA methylation patterns of the serotonin transporter gene (SLC6A4) promoter and symptoms of depression and anxiety. The SLC6A4 promoter methylation has also been associated with frontal-limbic brain responses to negative stimuli. However, it is unclear how much of this association is confounded by DNA sequence variations. We utilized a monozygotic-twin within-pair discordance design, to test whether DNA methylation at specific CpG sites in the SLC6A4 promoter of peripheral cells is associated with greater frontal-limbic brain responses to negative stimuli (sadness and fear), independently of DNA sequence effects. In total 48 pairs of healthy 15-year-old monozygotic twins from the Quebec Newborn Twin Study, followed regularly since birth, underwent functional magnetic resonance imaging while conducting an emotion-processing task. The SLC6A4 promoter methylation level was assessed in saliva samples using pyrosequencing. Relative to the co-twins with lower SLC6A4 promoter methylation levels, twins with higher peripheral SLC6A4 methylation levels showed greater orbitofrontal cortical (OFC) activity and left amygdala-anterior cingulate cortex (ACC) and left amygdala-right OFC connectivity in response to sadness as well as greater ACC-left amygdala and ACC-left insula connectivity in response to fearful stimuli. By utilising a monozygotic-twin design, we provided evidence that associations between peripheral SLC6A4 promoter methylation and frontal-limbic brain responses to negative stimuli are, in part, independent of DNA sequence variations. Although causality cannot be determined here, SLC6A4 promoter methylation may be one of the mechanisms underlying how environmental factors influence the serotonin system, potentially affecting emotional processing through frontal-limbic areas.

Indexed as

DNA MethylationFearSadnessAdolescentAmygdalaFemaleGyrus CinguliHumansMagnetic Resonance ImagingMalePromoter Regions, GeneticQuebecSerotonin Plasma Membrane Transport ProteinsTwins, MonozygoticSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID30089832
PMCPMC6082838
OpenAlexW2887201198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.